Encapsulating resveratrol (~63% efficiency) inside exosomes derived from human dental pulp stem cells (hDPSC-Exos) and activating the complex with blue LED irradiation (240 seconds, sub-threshold dose) reduced mature Streptococcus mutans biofilm biomass by 84.7% and metabolic activity by 88.9%, with comparable results against Lactobacillus acidophilus (75.2% and 85.0%). Critically, virulence genes gtfB and slpA — governing glucan synthesis and bacterial adhesion respectively — were suppressed to just 0.15- and 0.19-fold of controls. Free resveratrol, empty exosomes, and LED alone each produced only 5–15% reductions, underscoring that synergy, not individual components, drives the effect.
Dental caries remains the most prevalent chronic disease globally, and biofilm resistance to conventional antimicrobials is a growing clinical problem. Photodynamic therapy using plant-derived photosensitizers has long been hampered by poor aqueous stability and tissue penetration — exactly the gap exosomal nanocarriers are positioned to fill. Exosomes' endogenous membrane architecture likely facilitates deeper biofilm penetration and protects resveratrol from oxidative degradation, amplifying reactive oxygen species generation upon LED activation. The virulence gene suppression is particularly notable: reducing gtfB expression could impair biofilm scaffold formation at a mechanistic level beyond simple bacterial killing.
Limitations are meaningful: this is an in vitro enamel-specimen model with no saliva flow, immune response, or polymicrobial complexity. The authors themselves flag the absence of a direct free-resveratrol-aPDT comparator as a design gap. Considered incremental but technically creative — clinical translation requires in vivo validation.